22157.jpg
Large Molecule Drug Substance CDMO Global Market to 2030: Increasing Large Molecule Drug Approvals Drives Growth
March 20, 2023 11:48 ET | Research and Markets
Dublin, March 20, 2023 (GLOBE NEWSWIRE) -- The "Large Molecule Drug Substance CDMO Market Size, Share & Trends Analysis Report By Service (Contract Manufacturing, Contract Development), By...
Global Bioprocess Validation Market
Global Bioprocess Validation Market Report 2023: Rising Usage of Single Use Bioprocessing Drives Growth
March 15, 2023 07:18 ET | Research and Markets
Dublin, March 15, 2023 (GLOBE NEWSWIRE) -- The "Global Bioprocess Validation Market Size, Share & Industry Trends Analysis Report By Stage, By Mode, By Testing Type, By Regional Outlook and...
Global U.S. Biopharmaceutical CMO & CRO Market
U.S. Biopharmaceutical CMO & CRO Market Report 2023: Need for Flexible and Scalable Manufacturing Solutions Fuels Growth
March 13, 2023 07:03 ET | Research and Markets
Dublin, March 13, 2023 (GLOBE NEWSWIRE) -- The "U.S. Biopharmaceutical CMO & CRO Market Size, Share & Trends Analysis Report By Source (Mammalian, Non-mammalian), By Service (Contract...
Global Advanced Therapy Medicinal Products CDMO Market
Global Advanced Therapy Medicinal Products CDMO Market Report 2023: Rising Need for CDMOS Due to Increasing Number of ATMP Clinical Trials
February 28, 2023 08:18 ET | Research and Markets
Dublin, Feb. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Advanced Therapy Medicinal Products CDMO Market Size, Share & Industry Trends Analysis Report By Indication, By Product, By Phase, By...
Global Biologics Development and Manufacturing Testing Market
Global Biologics Development and Manufacturing Testing Market Report 2023: Sector to Reach $18.2 Billion by 2027 at a CAGR of 19.9%
February 24, 2023 09:38 ET | Research and Markets
Dublin, Feb. 24, 2023 (GLOBE NEWSWIRE) -- The "Biologics Development and Manufacturing Testing: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. This...
22157.jpg
Europe Large Molecule Drug Substance CDMO Market Report 2022: Featuring Eurofins Scientific, Catalent, Samsung Biologics, Boehringer Ingelheim & More
February 22, 2023 11:38 ET | Research and Markets
Dublin, Feb. 22, 2023 (GLOBE NEWSWIRE) -- The "Europe Large Molecule Drug Substance CDMO Market Size, Share & Industry Trends Analysis Report By Application (Mammalian, Microbial and Others), By...
large-molecule-drug-substance-cdmo-market-share.jpg
Global Large Molecule Drug Substance CDMO Market Report 2022: Growing Cardiovascular Diseases (CVD) And CVD-Induced Deaths Bolsters Demand
January 31, 2023 10:58 ET | Research and Markets
Dublin, Jan. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Large Molecule Drug Substance CDMO Market Size, Share & Industry Trends Analysis Report By Application (Mammalian, Microbial and Others), By...
22157.jpg
Global ADC (Anti-body-Drug Conjugates) Contract Manufacturing Markets, 2022-2035: An in-depth Analysis of Over 80 ADC Based Therapy Developers Likely to Partner with Contract Service Providers
January 16, 2023 05:08 ET | Research and Markets
Dublin, Jan. 16, 2023 (GLOBE NEWSWIRE) -- The "ADC Contract Manufacturing Market by Phase of Development, Scale of Operation, Type of Component Manufacturing, Target Indications, Type of Payload,...
22157.jpg
Latest Process Validation Guidance Requirements course (FDA and EU Annex 15: Qualifications and Validation) (January 25-26, 2023)
January 13, 2023 06:28 ET | Research and Markets
Dublin, Jan. 13, 2023 (GLOBE NEWSWIRE) -- The "Latest Process Validation Guidance Requirements course (FDA and EU Annex 15: Qualifications and Validation)" training has been added to ...
22157.jpg
Cell Line Development Services Global Market Report 2022: Industry to Reach $2.09 Billion by 2030 with Increasing Demand for Biologics and Biosimilars Driving Growth
December 28, 2022 05:18 ET | Research and Markets
Dublin, Dec. 28, 2022 (GLOBE NEWSWIRE) -- The "Cell Line Development Services Global Market - Forecast To 2030" report has been added to ResearchAndMarkets.com's offering. The cell line...